Drugs / NAC
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02483143 Comparator | Feb 2014 → Feb 2015 | pulmonary embolism | Karadeniz Technical University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NAC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02483143 ↗ |
| Route | Intravenous | “The groups received 3 mL/kg intravenous (IV) NAC+NS or NaHCO3 +NS solution or NS alone 1 hour before CTPA and 1 mL/kg IV per hour for a minimum of 6 hours after CTPA.” PMID 27411777 ↗ Sep 2016 |